and said the panel failed to take into account Humana's response pointing out errors. The report acknowledged that regulators collect data on Medicare Advantage plans' use of prior authorization ...

It outlines attempts from UnitedHealthcare, CVS and Humana—which collectively cover nearly 60% of all MA enrollees—to use technology to reject prior authorization claims, all while reaping profit.

Former Humana CEO and president Bruce Broussard will be joining VC firm Define Ventures as a venture partner, Fortune can ...

4. From 2019 and 2022, UnitedHealthcare, Humana, and CVS Health each denied prior authorization requests for post-acute care at far higher rates than they did for other types of care, resulting in ...

LAS VEGAS — Blue Shield of California and Salesforce, a cloud-based customer relation management company, announced a partnership on Monday that aims to cut down the prior authorization process ...

Prior to joining Forbes Health ... only available in select states According to a Humana customer service representative, its networks are regionally based. Each plan has its own set of providers ...

Humana provides three types of Medicare coverage options for Medicare users. Its Medigap plans are designed to help seniors afford the cost of healthcare by covering items not traditionally ...

Esperion Therapeutics' aggressive commercialization efforts have significantly boosted retail prescriptions and broadened ...

If Cigna and Humana were to come together, they would form a company that could potentially rival industry giants UnitedHealth Group and CVS Health. However, the feds have made it clear that they ...

Humana Inc.’s stock was up 2% Friday after three straight sessions of declines, but investors paying attention to the performance of its bonds on Thursday may have had something of a heads-up on ...

UHC and Humana are heavy hitters in the industry and available in most of the U.S. See how they compare. Many, or all, of the products featured on this page are from our advertising partners who ...

The subcommittee found that, between 2019 and 2022, UnitedHealthcare, Humana, and CVS each denied prior authorization requests for post-acute care “at far higher rates than they did for other ...